Clinical Trials Logo

Clinical Trial Summary

Assessment of the Pattern and Risk Factors of Covid-19 between infected Healthcare Workers at Assiut University Hospitals


Clinical Trial Description

COVID-19 is a respiratory infectious disease caused by a novel coronavirus, SARS-CoV-2. The first batch of COVID-19 patients were found in December 2019 (1). The disease is mainly transmitted through respiratory droplets and close contact, and all people are susceptible to it (2). SARS-CoV-2 is highly contagious (3), and has quickly spread to most countries and regions of the world. COVID-19 has become a global pandemic and has received great attention from all over the world (4, 5). Till April 7, 2020, 1,214,466 confirmed cases of COVID-19 have been found in 211 countries and regions, causing 67,767 deaths (6). The main clinical manifestations of COVID-19 are cough, fever, malaise, chest distress and tachypnia and complications such acute respiratory distress syndrome. Healthcare workers (HCWs) are on front line of treating patients infected with COVID-19. However, data related to infection rate among HCWs are limited. Early available evidence suggested that HCWs are being increasingly infected with the novel infection ranging from 15% to 18% and in some cases up to 20% of the infected population. Major risk factors of infection among HCWs include lack of understanding of the disease, inadequate use and availability personal Protective Equipment (PPE), uncertain diagnostic criteria, unavailability of diagnostic tests and psychological stress. Therefore the protection of HCWs by authorities should be prioritized through education and training, the readiness of staff, incentives, availability of PPEs, and psychological support. In this time of COVID-19 pandemic, big problem in hospitals that are flooded with infected symptomatic and asymptomatic patients. A critical aspect is the protection of the HCWs who are at risk, including individuals more than 50 years old those with presence of a systemic disease, smokers and disabled individuals. These HCWs should be identified and not assigned duties inwards and premises managing COVID 19 patients ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04646551
Study type Observational
Source Assiut University
Contact Sahar Ahmed Okily
Phone 01094504484
Email Sara3hmed2012@gmail.com
Status Not yet recruiting
Phase
Start date December 2020
Completion date January 2022

See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure